At ProMeta Therapeutics is dedicated to transforming cardiometabolic health by developing innovative, modular protein therapies that target obesity and related disorders. Our mission is to advance the boundaries of science and deliver life-changing treatments to improve patient lives.
ProMeta Therapeutics is at the forefront of engineering novel modular proteins to solve some of the most complex challenges in cardiometabolic diseases, starting with obesity. Our pioneering approach aims to create multifunctional proteins that offer precise solutions for metabolic health through "mix-and-match" modular design with clinically validated targets. We are actively building a strong scientific foundation to redefine how these conditions are treated, with the ultimate goal of developing breakthrough therapies for patients around the world.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.